Difference between revisions of "Marburg virus"
(worth keeping an eye on) |
(|constitutes=Disease, Virus) |
||
Line 1: | Line 1: | ||
{{concept | {{concept | ||
|wikipedia=https://en.wikipedia.org/wiki/Marburg_virus | |wikipedia=https://en.wikipedia.org/wiki/Marburg_virus | ||
− | |constitutes= | + | |constitutes=Disease, Virus |
|image=Marburg virus.jpg | |image=Marburg virus.jpg | ||
|description=A virus spruiked by corporate media in 2021 as the next big thing, despite only a handful of deaths since 2005. Super-deadly but apparently now with asymptomatic infection (i.e no symptoms) that can be detected with a [[PCR test]] . | |description=A virus spruiked by corporate media in 2021 as the next big thing, despite only a handful of deaths since 2005. Super-deadly but apparently now with asymptomatic infection (i.e no symptoms) that can be detected with a [[PCR test]] . | ||
}} | }} | ||
− | The '''Marburg virus''' is a single-stranded RNA Virus named after Marburg, the [[German]] city where it first appeared in [[Europe]]. In the last half of 2021 corporate media started warning of a possible epidemic. By remarkable chance a [[PCR-test]] able to give massive amounts of false positive results, a [[RNA vaccine]] (both despite only 16 deaths since 2005) and a growing avalanche of injuries from the coerced mass-injections of RNA vaccines (the [[COVID-19/Vaccine|COVID-19/Vaccines]]), were already in place<ref name=indy>http://www.indymedia.ie/article/108016</ref>. | + | The '''Marburg virus''' is a single-stranded RNA Virus named after Marburg, the [[German]] city where it first appeared in [[Europe]]. In the last half of [[2021]] corporate media started warning of a possible epidemic. By remarkable chance a [[PCR-test]] able to give massive amounts of false positive results, a [[RNA vaccine]] (both despite only 16 deaths since [[2005]]) and a growing avalanche of injuries from the coerced mass-injections of RNA vaccines (the [[COVID-19/Vaccine|COVID-19/Vaccines]]), were already in place<ref name=indy>http://www.indymedia.ie/article/108016</ref>. |
==Official narrative== | ==Official narrative== | ||
− | The Marburg virus belongs to the Filoviridae family. This family of viruses is responsible for some of the most pathogenic viral infections in humans. Although quite close to the [[Ebola virus]], it is known to be less lethal than the latter. It nevertheless represents a sufficiently high biological hazard that it can only be handled in a P4 or BSL-4 laboratory (biosafety level 4 laboratory) 3,4. The first known cases appeared among researchers in [[Germany]] in 1967, before the development of two major epidemics in 2000, in the Democratic Republic of the Congo and in 2005, in [[Angola]]. | + | The Marburg virus belongs to the Filoviridae family. This family of viruses is responsible for some of the most pathogenic viral infections in humans. Although quite close to the [[Ebola virus]], it is known to be less lethal than the latter. It nevertheless represents a sufficiently high biological hazard that it can only be handled in a P4 or BSL-4 laboratory (biosafety level 4 laboratory) 3,4. The first known cases appeared among researchers in [[Germany]] in 1967, before the development of two major epidemics in [[2000]], in the [[Democratic Republic of the Congo]] and in 2005, in [[Angola]]. |
− | Like the [[Ebola virus]], Marburg viruses can infect many different cell types. After an incubation period of usually three to nine days, but no longer than 21 days, the first unspecific symptoms appear, which are similar to the initial symptoms of malaria, typhoid or yellow fever. These symptoms include severe, watery diarrhea, abdominal pain, vomiting, severe chest and lung pain, sore throat, and cough. In a high percentage of those infected, the virus triggers a high hemorrhagic fever five to seven days after the onset of the disease, which predominantly affects the gastrointestinal tract and lungs. | + | Like the [[Ebola virus]], Marburg viruses can infect many different cell types. After an incubation period of usually three to nine days, but no longer than 21 days, the first unspecific symptoms appear, which are similar to the initial symptoms of [[malaria]], typhoid or yellow fever. These symptoms include severe, watery diarrhea, abdominal pain, vomiting, severe chest and lung pain, sore throat, and cough. In a high percentage of those infected, the virus triggers a high hemorrhagic fever five to seven days after the onset of the disease, which predominantly affects the gastrointestinal tract and lungs. |
− | The mortality from this disease varies greatly, depending on medical care and the virus strain, between 22.6% (outbreak 1967) and 88.0% in Uige (Angola, 2004–2005).For example, the strain found in Angola had a higher virulence than the strain found in Germany in 1967. Even if the high mortality is rather disadvantageous for the spread of the virus, the virus is nonetheless well adapted to its ultimate host, humans, since a high level of contagiousness is reached due to the viral load that causes the high mortality. | + | The mortality from this disease varies greatly, depending on medical care and the virus strain, between 22.6% (outbreak 1967) and 88.0% in Uige (Angola, 2004–2005).For example, the strain found in Angola had a higher virulence than the strain found in Germany in [[1967]]. Even if the high mortality is rather disadvantageous for the spread of the virus, the virus is nonetheless well adapted to its ultimate host, humans, since a high level of contagiousness is reached due to the viral load that causes the high mortality. |
==Points of interest== | ==Points of interest== | ||
Line 25: | Line 25: | ||
* A paper tilled Asymptomatic Infection of Marburg Virus was published by the [[NIH]] in January 2021.<ref>https://pubmed.ncbi.nlm.nih.gov/33157026/</ref> | * A paper tilled Asymptomatic Infection of Marburg Virus was published by the [[NIH]] in January 2021.<ref>https://pubmed.ncbi.nlm.nih.gov/33157026/</ref> | ||
*[[Jon Rappoport]] reported that chemist [[David Rasnick]], PhD, has examined published literature on Ebola, and has concluded: “I have examined in detail the literature on isolation and EMs [EM: electron microscope pictures] of both [[Ebola]] and Marburg viruses. I have not found any convincing evidence that Ebola virus (and for that matter Marburg) has been isolated from humans. There is certainly no confirmatory evidence of human isolation.”<ref>https://blog.nomorefakenews.com/2014/11/07/watch-out-genetically-engineered-ebola-vaccine/</ref> | *[[Jon Rappoport]] reported that chemist [[David Rasnick]], PhD, has examined published literature on Ebola, and has concluded: “I have examined in detail the literature on isolation and EMs [EM: electron microscope pictures] of both [[Ebola]] and Marburg viruses. I have not found any convincing evidence that Ebola virus (and for that matter Marburg) has been isolated from humans. There is certainly no confirmatory evidence of human isolation.”<ref>https://blog.nomorefakenews.com/2014/11/07/watch-out-genetically-engineered-ebola-vaccine/</ref> | ||
− | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} |
Revision as of 14:45, 25 October 2021
Marburg virus (Disease, Virus) | |
---|---|
A virus spruiked by corporate media in 2021 as the next big thing, despite only a handful of deaths since 2005. Super-deadly but apparently now with asymptomatic infection (i.e no symptoms) that can be detected with a PCR test . |
The Marburg virus is a single-stranded RNA Virus named after Marburg, the German city where it first appeared in Europe. In the last half of 2021 corporate media started warning of a possible epidemic. By remarkable chance a PCR-test able to give massive amounts of false positive results, a RNA vaccine (both despite only 16 deaths since 2005) and a growing avalanche of injuries from the coerced mass-injections of RNA vaccines (the COVID-19/Vaccines), were already in place[1].
Official narrative
The Marburg virus belongs to the Filoviridae family. This family of viruses is responsible for some of the most pathogenic viral infections in humans. Although quite close to the Ebola virus, it is known to be less lethal than the latter. It nevertheless represents a sufficiently high biological hazard that it can only be handled in a P4 or BSL-4 laboratory (biosafety level 4 laboratory) 3,4. The first known cases appeared among researchers in Germany in 1967, before the development of two major epidemics in 2000, in the Democratic Republic of the Congo and in 2005, in Angola.
Like the Ebola virus, Marburg viruses can infect many different cell types. After an incubation period of usually three to nine days, but no longer than 21 days, the first unspecific symptoms appear, which are similar to the initial symptoms of malaria, typhoid or yellow fever. These symptoms include severe, watery diarrhea, abdominal pain, vomiting, severe chest and lung pain, sore throat, and cough. In a high percentage of those infected, the virus triggers a high hemorrhagic fever five to seven days after the onset of the disease, which predominantly affects the gastrointestinal tract and lungs.
The mortality from this disease varies greatly, depending on medical care and the virus strain, between 22.6% (outbreak 1967) and 88.0% in Uige (Angola, 2004–2005).For example, the strain found in Angola had a higher virulence than the strain found in Germany in 1967. Even if the high mortality is rather disadvantageous for the spread of the virus, the virus is nonetheless well adapted to its ultimate host, humans, since a high level of contagiousness is reached due to the viral load that causes the high mortality.
Points of interest
- Biontech is producing its COVID-19 vaccine at its factory in Marburg, Germany, one of the largest mRNA vaccine manufacturing sites in Europe as well as worldwide with an annual production capacity of up to one billion doses.[2]
- Bill Gates' GAVI published an article on 22-Apr-2021 titled “The next pandemic: Marburg?”. There have been numerous corporate media articles highlighting an upcoming threat Marburg and referencing the WHO in recent months.[3][1]
- Marburg Virus is a relatively rare haemorrhagic fever which was first described in 1967, there have only been a total of 376 related deaths, and only 16 deaths since 2005.
- The company Primerdesign developed a one-step Real-Time PCR test genesig® in 2018 for Marburg haemorrhagic fever. Why would they develop a test in 2018 for an illness which has not had a major outbreak since 2005?[4][1]
- Soligenix, are per 2021 rushing to trial a ricin-rich vaccine RiVax® for Marburg haemorrhagic fever. RiVax has Fast Track designation for the prevention of ricin intoxication by the US FDA. [5]Approval of ricin toxin vaccine will utilize the FDA Animal Rule to eliminate the phase 1, 2 & 3 trials. This is a strange hurry to approve a vaccine for which there has only been a total of 376 deaths since 1967 and only 16 deaths since 2005? The main component of the Rivax vaccine is Ricin is a lectin and a highly potent toxin produced in the seeds of the castor oil plant.[1]
- Soligenix shareholders include BlackRrock Fund Advisors, Goldman Sachs & Co. LLC, etc.[6]
- Ricin is a lectin and a highly potent toxin produced in the seeds of the castor oil plant. Ricin is very toxic if inhaled, injected, or ingested. It acts as a toxin by inhibiting protein synthesis. It prevents cells from assembling various amino acids into proteins according to the messages it receives from messenger RNA in a process conducted by the cell’s ribosome (the protein-making machinery) – that is, the most basic level of cell metabolism, essential to all living cells and thus to life itself.[1]
- A paper tilled Asymptomatic Infection of Marburg Virus was published by the NIH in January 2021.[7]
- Jon Rappoport reported that chemist David Rasnick, PhD, has examined published literature on Ebola, and has concluded: “I have examined in detail the literature on isolation and EMs [EM: electron microscope pictures] of both Ebola and Marburg viruses. I have not found any convincing evidence that Ebola virus (and for that matter Marburg) has been isolated from humans. There is certainly no confirmatory evidence of human isolation.”[8]
References
- ↑ a b c d e http://www.indymedia.ie/article/108016
- ↑ https://investors.biontech.de/news-releases/news-release-details/biontech-provides-update-vaccine-production-status-marburg
- ↑ https://www.weforum.org/agenda/2021/08/marburg-diease-ebola-health-security-africa-guinea/
- ↑ https://www.genesig.com/assets/files/mbgv_std.pdf
- ↑ https://www.fda.gov/drugs/nda-and-bla-approvals/animal-rule-approvals
- ↑ https://money.cnn.com/quote/shareholders/shareholders.html?symb=SNGX&subView=institutional
- ↑ https://pubmed.ncbi.nlm.nih.gov/33157026/
- ↑ https://blog.nomorefakenews.com/2014/11/07/watch-out-genetically-engineered-ebola-vaccine/